Lung injury following thoracoscopic talc insufflation: Experience of a single North American Center

Chest

Volumn 137, Issue 6, 2010, Pages 1375-1381

  Gonzalez, Anne V ^a   Bezwada, Vishnu ^b   Beamis Jr , John F ^c   Villanueva, Andrew G ^c  

^a MCGILL UNIVERSITY   (Canada)

^b Yuma Regional Medical Center   (United States)

^c LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TALC;

AGED; ARTICLE; DYSPNEA; FEMALE; HUMAN; LUNG INJURY; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PLEURA EFFUSION; PRIORITY JOURNAL; RESPIRATORY FAILURE; SPONTANEOUS PNEUMOTHORAX; THORACOSCOPY; THORAX RADIOGRAPHY;

EID: 77953320342     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-2020     Document Type: Article

References (29)

1. Walker-Renard PB, Vaughan LM, Sahn SA. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med. 1994;120(1):56-64. (Pubitemid 24011502)
2. Shaw P, Agarwal R. Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev. 2004 ;(1):CD002916.
3. Tan C, Sedrakyan A, Browne J, Swift S, Treasure T. The evidence on the effectiveness of management for malignant pleural effusion:a systematic review. Eur J Cardiothorac Surg. 2006;29(5):829-838.
4. Kennedy L, Sahn SA. Talc pleurodesis for the treatment of pneumothorax and pleural effusion. Chest. 1994;106(4): 1215-1222. (Pubitemid 24309565)
5. Light RW. Talc should not be used for pleurodesis. Am J Respir Crit Care Med. 2000;162(6):2024-2026. (Pubitemid 32051656)
6. Rinaldo JE, Owens GR, Rogers RM. Adult respiratory distress syndrome following intrapleural instillation of talc. J Thorac Cardiovasc Surg. 1983;85(4):523-526. (Pubitemid 13091283)
7. Bouchama A, Chastre J, Gaudichet A, Soler P, Gibert C. Acute pneumonitis with bilateral pleural effusion after talc pleurodesis. Chest. 1984;86(5):795-797. (Pubitemid 15217666)
8. Campos JRM, Werebe EC, Vargas FS, Jatene FB, Light RW. Respiratory failure due to insufflated talc. Lancet. 1997; 349(9047):251-252.
9. Rehse DH, Aye RW, Florence MG. Respiratory failure following talc pleurodesis. Am J Surg. 1999;177(5):437-440.
10. Janssen JP, Collier G, Astoul P, et al. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet. 2007;369(9572):1535-1539.
11. Ferrer J, Villarino MA, Tura JM, Traveria A, Light RW. Talc preparations used for pleurodesis vary markedly from one preparation to another. Chest. 2001;119(6):1901-1905.
12. Noppen M. Who's (still) afraid of talc? Eur Respir J. 2007;29(4):619-621.
13. Villanueva AG, Beamis JF. Medical thoracoscopy: diagnosis of pleural pulmonary disorders. In: Beamis JF, Mathur PN, Mehta AC, eds. Interventional Pulmonary Medicine. New York, NY: Marcel Dekker; 2004:431-449.
14. Mathur PN, Astoul P, Boutin C. Medical thoracoscopy. Technical details. Clin Chest Med. 1995;16(3):479-486.
15. Bethune N. Pleural poudrage: new technique for the deliberate production of pleural adhesion as preliminary to lobectomy. J Thorac Surg. 1935;4:251-261.
16. Dresler CM, Olak J, Herndon JE II, et al; Cooperative Groups Cancer and Leukemia Group B;Eastern Cooperative Oncology Group; North Central Cooperative Oncology Group; Radiation Therapy Oncology Group. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest. 2005;127(3):909-915.
17. Kennedy L, Rusch VW, Strange C, Ginsberg RJ, Sahn SA. Pleurodesis using talc slurry. Chest. 1994;106(2):342-346.
18. de Campos JRM, Vargas FS, de Campos Werebe E, et al. Thoracoscopy talc poudrage: a 15-year experience. Chest. 2001; 119(3):801-806.
19. Weissberg D, Ben-Zeev I. Talc pleurodesis. Experience with 360 patients. J Thorac Cardiovasc Surg. 1993;106(4): 689-695. (Pubitemid 23310449)
20. Viallat JR, Rey F, Astoul P, Boutin C. Thoracoscopic talc poudrage pleurodesis for malignant effusions. A review of 360 cases. Chest. 1996;110(6):1387-1393. (Pubitemid 26425133)
21. Györik S, Erni S, Studler U, Hodek-Wuerz R, Tamm M, Chhajed PN. Long-term follow-up of thoracoscopic talc pleurodesis for primary spontaneous pneumothorax. Eur Respir J. 2007;29(4):757-760. (Pubitemid 46554627)
22. Mahfood S, Hix WR, Aaron BL, Blaes P, Watson DC. Reexpansion pulmonary edema. Ann Thorac Surg. 1988;45(3): 340-345.
23. Montes JF, Ferrer J, Villarino MA, Baeza B, Crespo M, Garcia-Valero J. Influence of talc dose on extrapleural talc dissemination after talc pleurodesis. Am J Respir Crit Care Med. 2003;168(3):348-355.
24. American Thoracic Society. Management of malignant pleural effusions. Am J Respir Crit Care Med. 2000;162(5):1987-2001.
25. Kuzniar TJ, Blum MG, Kasibowska-Kuzniar K, Mutlu GM. Predictors of acute lung injury and severe hypoxemia in patients undergoing operative talc pleurodesis. Ann Thorac Surg. 2006;82(6):1976-1981.
26. Navarro Jiménez C, Gómez Izquierdo L, Sánchez Gutiérrez C, et al. Análisis morfométrico y mineralógico de 14 muestras de talco usado para pleurodesis en distintos países de Europa y América. Neumosur. 2005;17(3):197-202.
27. Li J. Ultrastructural study on the pleural stomata in human. Funct Dev Morphol. 1993;3(4):277-280.
28. Ferrer J, Montes JF, Villarino MA, Light RW, García-Valero J. Influence of particle size on extrapleural talc dissemination after talc slurry pleurodesis. Chest. 2002;122(3):1018-1027.
29. Maskell NA, Lee YC, Gleeson FV, Hedley EL, Pengelly G, Davies RJ. Randomized trials describing lung inflammation after pleurodesis with talc of varying particle size. Am J Respir Crit Care Med. 2004;170(4):377-382.